- Email: [email protected]
Subject index, Volume 189 (2006)
Atherosclerosis 189 (2006) 484–486
Subject index Volume 189 (2006) ACE I/D polymorphsim 189, 474 Acetylated LDL 189, 142 Acute coronary syndrome 189, 70 Adiponectin 189, 401 Adipophilin 189, 142 Aging 189, 387 Akt 189, 350 Angiographic trial 189, 375 Angioplasty 189, 123 Ankle-brachial index 189, 61 Annexin II 189, 76 Antioxidants 189, 115, 342 Apheresis 189, 31 ApoA-I 189, 215 ApoA–V 1131T > C polymorphism 189, 163 ApoA–V 189, 163 apoE deficient mouse 189, 282 Apolipoprotein AI 189, 255 Apolipoprotein-A1 189, 206 Apolipoproteins 189, 178, 318 Apoptosis 189, 464 Arterial remodelling 189, 123 Arteriosclerosis 189, 297 Artery wall 189, 387 Asymmetric dimethylarginine 189, 236 Atherosclerosis resistant strains 189, 336 Atherosclerosis 189, 31, 47, 83, 99, 106, 133, 142, 215, 229, 264, 303, 318, 328, 364, 393, 414, 436, 464, 478 AU-rich elements 189, 310 Autoantibodies 189, 364 bFGF 189, 303 Body mass index
189, 420
CAM 189, 39 Cardiovascular disease risk factors 189, 1 Cardiovascular diseases 189, 19, 61, 178, 364, 393 Cardiovascular fitness 189, 157 9-cis -carotene 189, 215 9-cis retinoic acid 189, 215 Carotid arteries 189, 178, 414 Carotid artery wall 189, 393 Carotid 189, 222 Chemokines 189, 458 Chitotriosidase 189, 318 Cholesterol efflux 189, 336 Cholesterol 189, 31, 264, 328, 369, 420 Chymase 189, 8 Cilostazol 189, 350 doi:10.1016/S0021-9150(06)00630-7
CLA 189, 318 Collagen 189, 91 Conjugated linoleic acid 189, 282 Contractions 189, 358 Coronary artery bypass surgery 189, 375 CORONARY artery disease (CAD) 189, 31, 229, 458, 470 Coronary calcium 189, 157 Coronary heart disease 189, 157, 206 Coronary severity 189, 206 C-reactive protein 189, 464 CRP 189, 169 CXCL16 189, 470 Defenestration 189, 273 Degeneration 189, 91 Diabetes mellitus 189, 241 Diabetes 189, 149, 282, 369 Diet 189, 478 Eicosapentaenoic acid 189, 115 Electron beam tomography 189, 157 Endothelial cells 189, 133, 350 Endothelial dysfunction 189, 47 Endothelial nitric oxide synthase 189, 241 Endothelial progenitor cells 189, 70, 247, 288 Endothelium 189, 247, 310, 342, 358 eNOS 189, 350 Environment 189, 169 Eotaxin (CCL11) 189, 458 Epidemiology 189, 222, 364, 428, 464 Estrogen 189, 76, 436 Exercise testing 189, 157 Experimental atherosclerosis 189, 282 Familial hypercholesterolaemia 189, 443 Familial hypercholesterolemia 189, 451 Fatty liver 189, 198 Femoral arteries 189, 178 Fibrinogen 189, 169 Fish oil 189, 19 Folate 189, 133 Fractalkine 189, 106 Free fatty acids 189, 310 Gene therapy 189, 123 Gene–gene interaction 189, 443 Genetic polymorphism 189, 443 Genetics 189, 169, 222 Genotype 189, 458
Subject index -Glutamyltransferase 189, 297 Glucose 189, 369 Haplotypes 189, 241 HDL proteolysis 189, 8 HDL 189, 255, 303 HDL–cholesterol 189, 206, 215 Heart failure 189, 247 Heart 189, 91 High-affinity cholesterol efflux 189, 8 High-frequency ultrasound 189, 387, 393 Hip circumference 189, 420 Homocysteine 189, 133, 236 Human apoA-I 189, 215 Human apoAI 189, 255 HuR 189, 310 Hypercholesterolemia 189, 115, 358 Hyperlipidemia 189, 273 Hypertension 189, 241, 369 Inflammation 189, 198, 247, 414, 428, 436, 464 Inflammatory markers 189, 193 In-hospital mortality 189, 193 Innate immune system 189, 408 Interactions 189, 169 Interleukin-18 189, 414 Interleukin-6 189, 193 Intima/media thickness ratio 189, 387 Intima-media thickness (IMT) 189, 393 Intravascular ultrasound 189, 229 Ischaemic stroke 189, 193 LDL apheresis 189, 31 LDL cholesterol 189, 31 LDL particle size 189, 206 LDLr/ apoB100/100 189, 328 Leptin 189, 47 Lipid metabolism 189, 328 Lipids 189, 222, 369, 420, 436 Lipoic acid 189, 115 -Lipoic acid 189, 106 Lipopolysaccharides 189, 408 Lipoprotein lipase 189, 310 Lipoproteins 189, 99, 264, 451 Liver sieve 189, 273 Liver sinusoidal endothelial cells 189, 273 Lp-PLA2 189, 149 Macrophages 189, 76, 142, 336 Macrovascular disease 189, 236 Mast cells 189, 8 Matrix metalloproteinases 189, 76 Matrix 189, 91 Maximum walking distance 189, 39 MCP-1 189, 336 Men 189, 297 Menopausal estrogen therapy 189, 387 Meta-analysis 189, 19, 39 Metabolic syndrome 189, 149, 198, 369, 401 Mice 189, 99 Microvessels 189, 123 Mitochondria 189, 328 MM-LDL 189, 303 Monocyte chemoattractant protein-1 189, 133 Monocyte recruitment 189, 336 Mortality 189, 186
Myocardial infarction 189, 186, 297, 458, 474 Neointimal hyperplasia 189, 106 NF-B 189, 106 Nitric oxide 189, 47, 247, 350 Obese children 189, 401 Obesity 189, 47, 420 Omega-3 fatty acid 189, 19 Oxidation 189, 364 Oxidative stress 189, 47, 198 Oxidised LDL 189, 149 oxLDL 189, 470 Padma 28 189, 39 PAFAH 189, 149 PAI-1 189, 401 Paraoxonase 189, 47, 318 Passive immunization 189, 83 Percutaneous coronary intervention 189, 70 Perilipin 189, 142 Peripheral arterial occlusive disease (PAOD) 189, 39 Phosphorylcholine 189, 83 Phytotherapy 189, 39 PKA 189, 350 Plasma levels 189, 458 Plasma lipoproteins 189, 282 Polymorphisms 189, 241 Postmenopausal hormone therapy 189, 375 Postprandial lipemia 189, 163 Pre-HDL 189, 8 Pregnancy 189, 451 Primary angioplasty 189, 186 Primary prevention 189, 157 Pyrosequencing 189, 458 Remodeling 189, 229 Restenosis 189, 342 Reverse cholesterol transport 189, 8 Risk factors 189, 297, 364 Saphenous vein graft 189, 375 SCAP 189, 443 Senescence 189, 288 Serine palmitoyltransferase 189, 264 Serum lipids 189, 451 Single nucleotide polymorphism 189, 458 Sirolimus 189, 288 Small dense LDL–cholesterol 189, 206 SMC 189, 336 Smooth muscle cells 189, 303 Sphingolipid 189, 264 SREBP 189, 264, 443 SR-PSOX 189, 470 Statins 189, 76, 186, 408 Stents 189, 342 Systematic review 189, 19 Tea consumption 189, 428 Telomerase activity 189, 288 Thrombosis 189, 342 Thromboxane 189, 358 Tibetan herbal drug 189, 39 Toll-like receptor 189, 408 Transgenic mice 189, 255 Triacylglycerol 189, 163
485
486 Tryptase 189, 8 Type 2 diabetes mellitus
Subject index
189, 236
Ultrasonography 189, 178 Ultrasound 189, 414 Uric acid 189, 401 Valve 189, 91 Vascular endothelial growth factor 189, 123 Vascular endothelium 189, 70
Vascular smooth muscle cell 189, 99, 106 Vascular structure and function measures 189, 1 VEGF 189, 70 VLDL 189, 310 Waist circumference 189, 420 Waist–hip ratio 189, 420 Young adults
189, 1
Subject index Volume 189 (2006) ACE I/D polymorphsim 189, 474 Acetylated LDL 189, 142 Acute coronary syndrome 189, 70 Adiponectin 189, 401 Adipophilin 189, 142 Aging 189, 387 Akt 189, 350 Angiographic trial 189, 375 Angioplasty 189, 123 Ankle-brachial index 189, 61 Annexin II 189, 76 Antioxidants 189, 115, 342 Apheresis 189, 31 ApoA-I 189, 215 ApoA–V 1131T > C polymorphism 189, 163 ApoA–V 189, 163 apoE deficient mouse 189, 282 Apolipoprotein AI 189, 255 Apolipoprotein-A1 189, 206 Apolipoproteins 189, 178, 318 Apoptosis 189, 464 Arterial remodelling 189, 123 Arteriosclerosis 189, 297 Artery wall 189, 387 Asymmetric dimethylarginine 189, 236 Atherosclerosis resistant strains 189, 336 Atherosclerosis 189, 31, 47, 83, 99, 106, 133, 142, 215, 229, 264, 303, 318, 328, 364, 393, 414, 436, 464, 478 AU-rich elements 189, 310 Autoantibodies 189, 364 bFGF 189, 303 Body mass index
189, 420
CAM 189, 39 Cardiovascular disease risk factors 189, 1 Cardiovascular diseases 189, 19, 61, 178, 364, 393 Cardiovascular fitness 189, 157 9-cis -carotene 189, 215 9-cis retinoic acid 189, 215 Carotid arteries 189, 178, 414 Carotid artery wall 189, 393 Carotid 189, 222 Chemokines 189, 458 Chitotriosidase 189, 318 Cholesterol efflux 189, 336 Cholesterol 189, 31, 264, 328, 369, 420 Chymase 189, 8 Cilostazol 189, 350 doi:10.1016/S0021-9150(06)00630-7
CLA 189, 318 Collagen 189, 91 Conjugated linoleic acid 189, 282 Contractions 189, 358 Coronary artery bypass surgery 189, 375 CORONARY artery disease (CAD) 189, 31, 229, 458, 470 Coronary calcium 189, 157 Coronary heart disease 189, 157, 206 Coronary severity 189, 206 C-reactive protein 189, 464 CRP 189, 169 CXCL16 189, 470 Defenestration 189, 273 Degeneration 189, 91 Diabetes mellitus 189, 241 Diabetes 189, 149, 282, 369 Diet 189, 478 Eicosapentaenoic acid 189, 115 Electron beam tomography 189, 157 Endothelial cells 189, 133, 350 Endothelial dysfunction 189, 47 Endothelial nitric oxide synthase 189, 241 Endothelial progenitor cells 189, 70, 247, 288 Endothelium 189, 247, 310, 342, 358 eNOS 189, 350 Environment 189, 169 Eotaxin (CCL11) 189, 458 Epidemiology 189, 222, 364, 428, 464 Estrogen 189, 76, 436 Exercise testing 189, 157 Experimental atherosclerosis 189, 282 Familial hypercholesterolaemia 189, 443 Familial hypercholesterolemia 189, 451 Fatty liver 189, 198 Femoral arteries 189, 178 Fibrinogen 189, 169 Fish oil 189, 19 Folate 189, 133 Fractalkine 189, 106 Free fatty acids 189, 310 Gene therapy 189, 123 Gene–gene interaction 189, 443 Genetic polymorphism 189, 443 Genetics 189, 169, 222 Genotype 189, 458
Subject index -Glutamyltransferase 189, 297 Glucose 189, 369 Haplotypes 189, 241 HDL proteolysis 189, 8 HDL 189, 255, 303 HDL–cholesterol 189, 206, 215 Heart failure 189, 247 Heart 189, 91 High-affinity cholesterol efflux 189, 8 High-frequency ultrasound 189, 387, 393 Hip circumference 189, 420 Homocysteine 189, 133, 236 Human apoA-I 189, 215 Human apoAI 189, 255 HuR 189, 310 Hypercholesterolemia 189, 115, 358 Hyperlipidemia 189, 273 Hypertension 189, 241, 369 Inflammation 189, 198, 247, 414, 428, 436, 464 Inflammatory markers 189, 193 In-hospital mortality 189, 193 Innate immune system 189, 408 Interactions 189, 169 Interleukin-18 189, 414 Interleukin-6 189, 193 Intima/media thickness ratio 189, 387 Intima-media thickness (IMT) 189, 393 Intravascular ultrasound 189, 229 Ischaemic stroke 189, 193 LDL apheresis 189, 31 LDL cholesterol 189, 31 LDL particle size 189, 206 LDLr/ apoB100/100 189, 328 Leptin 189, 47 Lipid metabolism 189, 328 Lipids 189, 222, 369, 420, 436 Lipoic acid 189, 115 -Lipoic acid 189, 106 Lipopolysaccharides 189, 408 Lipoprotein lipase 189, 310 Lipoproteins 189, 99, 264, 451 Liver sieve 189, 273 Liver sinusoidal endothelial cells 189, 273 Lp-PLA2 189, 149 Macrophages 189, 76, 142, 336 Macrovascular disease 189, 236 Mast cells 189, 8 Matrix metalloproteinases 189, 76 Matrix 189, 91 Maximum walking distance 189, 39 MCP-1 189, 336 Men 189, 297 Menopausal estrogen therapy 189, 387 Meta-analysis 189, 19, 39 Metabolic syndrome 189, 149, 198, 369, 401 Mice 189, 99 Microvessels 189, 123 Mitochondria 189, 328 MM-LDL 189, 303 Monocyte chemoattractant protein-1 189, 133 Monocyte recruitment 189, 336 Mortality 189, 186
Myocardial infarction 189, 186, 297, 458, 474 Neointimal hyperplasia 189, 106 NF-B 189, 106 Nitric oxide 189, 47, 247, 350 Obese children 189, 401 Obesity 189, 47, 420 Omega-3 fatty acid 189, 19 Oxidation 189, 364 Oxidative stress 189, 47, 198 Oxidised LDL 189, 149 oxLDL 189, 470 Padma 28 189, 39 PAFAH 189, 149 PAI-1 189, 401 Paraoxonase 189, 47, 318 Passive immunization 189, 83 Percutaneous coronary intervention 189, 70 Perilipin 189, 142 Peripheral arterial occlusive disease (PAOD) 189, 39 Phosphorylcholine 189, 83 Phytotherapy 189, 39 PKA 189, 350 Plasma levels 189, 458 Plasma lipoproteins 189, 282 Polymorphisms 189, 241 Postmenopausal hormone therapy 189, 375 Postprandial lipemia 189, 163 Pre-HDL 189, 8 Pregnancy 189, 451 Primary angioplasty 189, 186 Primary prevention 189, 157 Pyrosequencing 189, 458 Remodeling 189, 229 Restenosis 189, 342 Reverse cholesterol transport 189, 8 Risk factors 189, 297, 364 Saphenous vein graft 189, 375 SCAP 189, 443 Senescence 189, 288 Serine palmitoyltransferase 189, 264 Serum lipids 189, 451 Single nucleotide polymorphism 189, 458 Sirolimus 189, 288 Small dense LDL–cholesterol 189, 206 SMC 189, 336 Smooth muscle cells 189, 303 Sphingolipid 189, 264 SREBP 189, 264, 443 SR-PSOX 189, 470 Statins 189, 76, 186, 408 Stents 189, 342 Systematic review 189, 19 Tea consumption 189, 428 Telomerase activity 189, 288 Thrombosis 189, 342 Thromboxane 189, 358 Tibetan herbal drug 189, 39 Toll-like receptor 189, 408 Transgenic mice 189, 255 Triacylglycerol 189, 163
485
486 Tryptase 189, 8 Type 2 diabetes mellitus
Subject index
189, 236
Ultrasonography 189, 178 Ultrasound 189, 414 Uric acid 189, 401 Valve 189, 91 Vascular endothelial growth factor 189, 123 Vascular endothelium 189, 70
Vascular smooth muscle cell 189, 99, 106 Vascular structure and function measures 189, 1 VEGF 189, 70 VLDL 189, 310 Waist circumference 189, 420 Waist–hip ratio 189, 420 Young adults
189, 1